Skip to main content
. 2017 Nov-Dec;33(6):1360–1365. doi: 10.12669/pjms.336.13692

Fig.1.

Fig.1

Surgical time in 255 patients undergoing total thyroidectomy for thyroid disease (Group-I – surgical hemostasis, Group-II – Surgicel, Group-III - fibrin-based haemostat). Data are expressed as mean ± SD; **p≤0.01 compared to Group-I; #p≤0.05 compared to Group-II.